跳至主要内容
临床试验/CTRI/2025/04/084145
CTRI/2025/04/084145尚未招募2 期

Clinical study to evaluate the Immunomodulatory effect of swarnaprashan in children under 5 years of age

Madan Mohan Malviya Government Ayurved College Udaipur1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年7月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Relief from recurrent infection

研究概览

简要总结

Children are vulnerable to infection because their immune system less developed. The urgent need for collective action to enhance children’s survival rates worldwide parallels the critical importance of childhood growth and development. Early childhood development is complex, involving various dimensions such as physical, social, emotional and mental aspects. so many vaccines are available for infectious diseases and antibiotics are successful in fighting the infections but emergence of antibiotic resistance is a great challenge in the present era. Also, frequent use of antibiotics creates lot of side-effects which also adversely affect the growth and development of the child. Childhood is a fragile age and too many vaccine shots and antibiotics may result in dangerous side effects in children. There is a strong need to develop nonspecific immunity in children which help them to fight against recurrent infections. Modern medical science lacks adequate management strategies to prevent such recurrences and enhance the immune system. However, ancient literature, particularly the Kashyap Samhita, provides us with valuable insights into immunomodulatory practices like Swarnaprashan, aimed at preventing children from infections and promoting their physical and mental growth.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
6.00 Month(s) 至 5.00 Year(s)(—)
性别
All

入选标准

  • Children aged between 06 Month to 05 years of either sex.
  • Children with recurrent respiratory infections.
  • Children with recurrence of fever and other infection.
  • Children with recurrence of gastro intestinal infection.
  • Children delay with growth and development.

排除标准

  • Children suffering from major systemic illness necessitating long term treatment.
  • Children with evidence of malignancy, genetic or congenital anomaly.
  • Co-morbidity like TB, UTI and bleeding disorders etc.

结局指标

主要结局

Relief from recurrent infection

时间窗: 28 days

and increase immunity

时间窗: 28 days

次要结局

  • compare the immunomodulatory effect of both group(28 days)

研究者

发起方
Madan Mohan Malviya Government Ayurved College Udaipur
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Saloni Ranawat

Madan Mohan Malviya Government Ayurved College

研究点 (1)

Loading locations...

相似试验